• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Relay Therapeutics, Inc. - Common Stock (NQ: RLAY )

    4.160 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,816
    Open 4.160
    Bid (Size) 4.180 (5)
    Ask (Size) 4.200 (8)
    Prev. Close 4.160
    Today's Range 4.160 - 4.160
    52wk Range 4.110 - 12.14
    Shares Outstanding 121,613,181
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant Demonstrating Continued Maturation of Clinically Meaningful Progression Free Survival
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    Relay Therapeutics to Present Updated Clinical Data on RLY-2608 in HR+/HER2- Breast Cancer at 2024 San Antonio Breast Cancer Symposium
    Company to host conference call on Wednesday, December 11, 2024 at 7am ET 
    From Relay Therapeutics, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -64.91%
    -64.91%
    1 Month
    -12.42%
    -12.42%
    3 Month
    -44.01%
    -44.01%
    6 Month
    -39.71%
    -39.71%
    1 Year
    -63.76%
    -63.76%

    More News

    Read More
    Relay Therapeutics and Elevar Therapeutics Announce Exclusive Global Licensing Agreement for Lirafugratinib in FGFR2-Driven Cholangiocarcinoma and Other Solid Tumors
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    Why Relay Therapeutics (RLAY) Stock Is Down 17% Today
    Via Benzinga
    Relay Therapeutics to Participate in Upcoming Investor Conferences
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    Relay Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Highlights
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, 2024
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    AI-Focused Drug Discovery Stocks +6% Last Week Vs. -8% Previous Week
    Via Talk Markets
    Why Relay Therapeutics Plummeted by Nearly 14% Today
    Via The Motley Fool
    This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday
    Via Benzinga
    GameStop Reports Weak Sales, Joins Petco, Relay Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    Why Dave & Buster's Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Relay Therapeutics Announces Pricing of Public Offering of Common Stock
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    Relay Therapeutics Faces Downgrade Over Efficacy Concerns in Competitive PI3K Inhibitor Market
    Via Benzinga
    AI-Focused Drug Discovery Stocks Portfolio -8% W/e Sept 6th
    Via Talk Markets
    This Johnson Controls International Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
    Via Benzinga
    Dow Jumps Over 1% Following Last Week's Selloff: Investor Sentiment Improves, But Fear & Greed Index Remains In 'Fear' Zone
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Relay Therapeutics Announces Proposed Public Offering of Common Stock
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    Crude Oil Gains Over 1%; Relay Therapeutics Shares Spike Higher
    Via Benzinga
    Exposures Fossil Fuels
    Nasdaq Surges Over 1%; US Wholesale Inventories Rise 0.2% In July
    Via Benzinga
    Relay Therapeutics Advances Towards Pivotal Trial As It Shares Encouraging Breast Cancer Data In Heavily Pretreated Patients
    Via Benzinga
    Terns Pharmaceuticals, Boeing, Tesla And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    US Stocks Higher; Dow Surges Over 200 Points
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Relay Therapeutics Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    Relay Therapeutics Announces Webcast to Report RLY-2608 Data on September 9, 2024
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.